We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Yun Li joined SAI MedPartners Asia in 2006. As a key member of Asia team, she has focused on providing broad strategic support to MNC and local pharma and medical device companies covering extensive scope of project types and therapeutic areas.
She supervises and manages project delivery and the project team with over 15 years of experience conducting in-depth interviews with senior management of major players in the healthcare industry, including regulators, medical device and pharmaceutical companies, physicians, distributors, drugstores, patients, and other industry experts.
Ms. Li has solid experience in a wide range of therapeutic areas, such as respiratory, rare diseases, immunology, oncology, cardiovascular, GI, infectious diseases, etc.
She has extensive experience in regulatory/policy analysis, new product market opportunity assessment, strategic market assessments, competitive analysis and benchmarking, assessment of M&A and licensing opportunities, and BD support
Notifications